Structure

Physi-Chem Properties

Molecular Weight:  554.29
Volume:  588.872
LogP:  7.691
LogD:  3.271
LogS:  -3.564
# Rotatable Bonds:  11
TPSA:  144.52
# H-Bond Aceptor:  8
# H-Bond Donor:  5
# Rings:  2
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.15
Synthetic Accessibility Score:  4.013
Fsp3:  0.438
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.203
MDCK Permeability:  1.1119746886834037e-05
Pgp-inhibitor:  0.859
Pgp-substrate:  0.732
Human Intestinal Absorption (HIA):  0.584
20% Bioavailability (F20%):  0.942
30% Bioavailability (F30%):  0.022

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.001
Plasma Protein Binding (PPB):  97.35523223876953%
Volume Distribution (VD):  1.363
Pgp-substrate:  5.03869104385376%

ADMET: Metabolism

CYP1A2-inhibitor:  0.054
CYP1A2-substrate:  0.713
CYP2C19-inhibitor:  0.532
CYP2C19-substrate:  0.57
CYP2C9-inhibitor:  0.663
CYP2C9-substrate:  0.978
CYP2D6-inhibitor:  0.052
CYP2D6-substrate:  0.141
CYP3A4-inhibitor:  0.086
CYP3A4-substrate:  0.235

ADMET: Excretion

Clearance (CL):  3.174
Half-life (T1/2):  0.042

ADMET: Toxicity

hERG Blockers:  0.003
Human Hepatotoxicity (H-HT):  0.836
Drug-inuced Liver Injury (DILI):  0.913
AMES Toxicity:  0.01
Rat Oral Acute Toxicity:  0.134
Maximum Recommended Daily Dose:  0.833
Skin Sensitization:  0.93
Carcinogencity:  0.034
Eye Corrosion:  0.003
Eye Irritation:  0.608
Respiratory Toxicity:  0.145

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC322301

Natural Product ID:  NPC322301
Common Name*:   1-[3-[1-[3-Acetyl-2,6-Dihydroxy-4-Methoxy-5-(3-Methylbut-2-Enyl)Phenyl]-3-Methylbutyl]-2,4,6-Trihydroxy-5-(3-Methylbut-2-Enyl)Phenyl]Ethanone
IUPAC Name:   1-[3-[1-[3-acetyl-2,6-dihydroxy-4-methoxy-5-(3-methylbut-2-enyl)phenyl]-3-methylbutyl]-2,4,6-trihydroxy-5-(3-methylbut-2-enyl)phenyl]ethanone
Synonyms:  
Standard InCHIKey:  KLFWXYAHGSXKAW-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C32H42O8/c1-15(2)10-12-20-27(35)23(18(7)33)30(38)25(28(20)36)22(14-17(5)6)26-29(37)21(13-11-16(3)4)32(40-9)24(19(8)34)31(26)39/h10-11,17,22,35-39H,12-14H2,1-9H3
SMILES:  CC(=CCc1c(c(C(=O)C)c(c(C(CC(C)C)c2c(c(CC=C(C)C)c(c(C(=O)C)c2O)OC)O)c1O)O)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL488313
PubChem CID:   159969
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0002279] Benzene and substituted derivatives
        • [CHEMONTID:0000369] Diphenylmethanes

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO12980 Acronychia pedunculata Species Rutaceae Eukaryota n.a. n.a. n.a. PMID[12880321]
NPO12980 Acronychia pedunculata Species Rutaceae Eukaryota n.a. bark n.a. PMID[22708987]
NPO12980 Acronychia pedunculata Species Rutaceae Eukaryota n.a. n.a. n.a. PMID[22708987]
NPO12980 Acronychia pedunculata Species Rutaceae Eukaryota n.a. n.a. n.a. PMID[2614422]
NPO40004 Acronychia trifoliolata Species Rutaceae Eukaryota n.a. n.a. n.a. PMID[27797192]
NPO40004 Acronychia trifoliolata Species Rutaceae Eukaryota n.a. n.a. n.a. PMID[27933896]
NPO40004 Acronychia trifoliolata Species Rutaceae Eukaryota n.a. n.a. n.a. PMID[31550158]
NPO12980 Acronychia pedunculata Species Rutaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO14356 Acronychia vestita Species Rutaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO12980 Acronychia pedunculata Species Rutaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO14356 Acronychia vestita Species Rutaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO12980 Acronychia pedunculata Species Rutaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO14356 Acronychia vestita Species Rutaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO12980 Acronychia pedunculata Species Rutaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT368 Cell Line SN12C Homo sapiens GI50 n.a. 468.81 nM PMID[568686]
NPT367 Cell Line MDA-N Homo sapiens GI50 n.a. 2157.74 nM PMID[568686]
NPT369 Cell Line ACHN Homo sapiens GI50 n.a. 1101.54 nM PMID[568686]
NPT370 Cell Line NCI-H23 Homo sapiens GI50 n.a. 275.42 nM PMID[568686]
NPT371 Cell Line UO-31 Homo sapiens GI50 n.a. 3076.1 nM PMID[568686]
NPT372 Cell Line HOP-92 Homo sapiens GI50 n.a. 190.99 nM PMID[568686]
NPT116 Cell Line HL-60 Homo sapiens GI50 n.a. 767.36 nM PMID[568686]
NPT374 Cell Line SF-539 Homo sapiens GI50 n.a. 1158.78 nM PMID[568686]
NPT90 Cell Line DU-145 Homo sapiens GI50 n.a. 2322.74 nM PMID[568686]
NPT375 Cell Line Malme-3M Homo sapiens GI50 n.a. 638.26 nM PMID[568686]
NPT373 Cell Line SK-MEL-5 Homo sapiens GI50 n.a. 481.95 nM PMID[568686]
NPT111 Cell Line K562 Homo sapiens GI50 n.a. 289.73 nM PMID[568686]
NPT376 Cell Line A498 Homo sapiens GI50 n.a. 84.33 nM PMID[568686]
NPT377 Cell Line OVCAR-3 Homo sapiens GI50 n.a. 1145.51 nM PMID[568686]
NPT112 Cell Line MOLT-4 Homo sapiens GI50 n.a. 644.17 nM PMID[568686]
NPT379 Cell Line HOP-62 Homo sapiens GI50 n.a. 1402.81 nM PMID[568686]
NPT378 Cell Line NCI/ADR-RES Homo sapiens GI50 n.a. 729.46 nM PMID[568686]
NPT380 Cell Line U-251 Homo sapiens GI50 n.a. 703.07 nM PMID[568686]
NPT381 Cell Line OVCAR-8 Homo sapiens GI50 n.a. 384.59 nM PMID[568686]
NPT382 Cell Line OVCAR-5 Homo sapiens GI50 n.a. 4897.79 nM PMID[568686]
NPT572 Cell Line DMS-273 Homo sapiens GI50 n.a. 332.66 nM PMID[568686]
NPT82 Cell Line MDA-MB-231 Homo sapiens GI50 n.a. 1640.59 nM PMID[568686]
NPT383 Cell Line SNB-19 Homo sapiens GI50 n.a. 1145.51 nM PMID[568686]
NPT384 Cell Line TK-10 Homo sapiens GI50 n.a. 1028.02 nM PMID[568686]
NPT385 Cell Line SR Homo sapiens GI50 n.a. 1104.08 nM PMID[568686]
NPT323 Cell Line SW-620 Homo sapiens GI50 n.a. 479.73 nM PMID[568686]
NPT573 Cell Line M19-MEL Homo sapiens GI50 n.a. 1425.61 nM PMID[568686]
NPT386 Cell Line KM12 Homo sapiens GI50 n.a. 997.7 nM PMID[568686]
NPT455 Cell Line NCI-H522 Homo sapiens GI50 n.a. 199.99 nM PMID[568686]
NPT574 Cell Line XF498 Homo sapiens GI50 n.a. 595.66 nM PMID[568686]
NPT387 Cell Line M14 Homo sapiens GI50 n.a. 1428.89 nM PMID[568686]
NPT388 Cell Line NCI-H322M Homo sapiens GI50 n.a. 422.67 nM PMID[568686]
NPT389 Cell Line RPMI-8226 Homo sapiens GI50 n.a. 418.79 nM PMID[568686]
NPT456 Cell Line OVCAR-4 Homo sapiens GI50 n.a. 1442.12 nM PMID[568686]
NPT390 Cell Line LOX IMVI Homo sapiens GI50 n.a. 1566.75 nM PMID[568686]
NPT457 Cell Line BT-549 Homo sapiens GI50 n.a. 1618.08 nM PMID[568686]
NPT147 Cell Line SK-MEL-2 Homo sapiens GI50 n.a. 503.5 nM PMID[568686]
NPT81 Cell Line A549 Homo sapiens GI50 n.a. 1798.87 nM PMID[568686]
NPT391 Cell Line HCC 2998 Homo sapiens GI50 n.a. 537.03 nM PMID[568686]
NPT392 Cell Line SNB-75 Homo sapiens GI50 n.a. 1686.55 nM PMID[568686]
NPT148 Cell Line HCT-15 Homo sapiens GI50 n.a. 399.94 nM PMID[568686]
NPT393 Cell Line HCT-116 Homo sapiens GI50 n.a. 325.09 nM PMID[568686]
NPT395 Cell Line SF-268 Homo sapiens GI50 n.a. 322.85 nM PMID[568686]
NPT394 Cell Line EKVX Homo sapiens GI50 n.a. 1035.14 nM PMID[568686]
NPT306 Cell Line PC-3 Homo sapiens GI50 n.a. 305.49 nM PMID[568686]
NPT83 Cell Line MCF7 Homo sapiens GI50 n.a. 385.48 nM PMID[568686]
NPT146 Cell Line SK-OV-3 Homo sapiens GI50 n.a. 2084.49 nM PMID[568686]
NPT576 Cell Line DMS-114 Homo sapiens GI50 n.a. 189.67 nM PMID[568686]
NPT397 Cell Line NCI-H460 Homo sapiens GI50 n.a. 588.84 nM PMID[568686]
NPT396 Cell Line T47D Homo sapiens GI50 n.a. 384.59 nM PMID[568686]
NPT308 Cell Line CAKI-1 Homo sapiens GI50 n.a. 1210.6 nM PMID[568686]
NPT398 Cell Line UACC-62 Homo sapiens GI50 n.a. 527.23 nM PMID[568686]
NPT400 Cell Line MDA-MB-435 Homo sapiens GI50 n.a. 1940.89 nM PMID[568686]
NPT399 Cell Line SF-295 Homo sapiens GI50 n.a. 521.19 nM PMID[568686]
NPT458 Cell Line IGROV-1 Homo sapiens GI50 n.a. 1702.16 nM PMID[568686]
NPT402 Cell Line Hs-578T Homo sapiens GI50 n.a. 1066.6 nM PMID[568686]
NPT577 Cell Line RXF 631 Homo sapiens GI50 n.a. 424.62 nM PMID[568686]
NPT401 Cell Line 786-0 Homo sapiens GI50 n.a. 1633.05 nM PMID[568686]
NPT578 Cell Line SNB-78 Homo sapiens GI50 n.a. 1698.24 nM PMID[568686]
NPT403 Cell Line UACC-257 Homo sapiens GI50 n.a. 1452.11 nM PMID[568686]
NPT579 Cell Line DLD-1 Homo sapiens GI50 n.a. 380.19 nM PMID[568686]
NPT404 Cell Line CCRF-CEM Homo sapiens GI50 n.a. 277.97 nM PMID[568686]
NPT139 Cell Line HT-29 Homo sapiens GI50 n.a. 722.77 nM PMID[568686]
NPT405 Cell Line NCI-H226 Homo sapiens GI50 n.a. 1235.95 nM PMID[568686]
NPT170 Cell Line SK-MEL-28 Homo sapiens GI50 n.a. 695.02 nM PMID[568686]
NPT406 Cell Line RXF 393 Homo sapiens GI50 n.a. 426.58 nM PMID[568686]
NPT407 Cell Line COLO 205 Homo sapiens GI50 n.a. 563.64 nM PMID[568686]
NPT732 Cell Line HOP-18 Homo sapiens GI50 n.a. 550.81 nM PMID[568686]
NPT570 Individual Protein Arachidonate 5-lipoxygenase Homo sapiens Activity < 50.0 % PMID[568687]
NPT570 Individual Protein Arachidonate 5-lipoxygenase Homo sapiens IC50 = 2300.0 nM PMID[568687]
NPT570 Individual Protein Arachidonate 5-lipoxygenase Homo sapiens IC50 = 2700.0 nM PMID[568687]
NPT81 Cell Line A549 Homo sapiens IC50 = 6100.0 nM PMID[568688]
NPT82 Cell Line MDA-MB-231 Homo sapiens IC50 = 6400.0 nM PMID[568688]
NPT91 Cell Line KB Homo sapiens IC50 = 4900.0 nM PMID[568688]
NPT956 Individual Protein Prostaglandin E synthase Homo sapiens IC50 = 1100.0 nM PMID[568687]
NPT2 Others Unspecified IC50 = 4400.0 nM PMID[568688]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC322301 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC255801
0.9704 High Similarity NPC476508
0.9695 High Similarity NPC16197
0.9618 High Similarity NPC15834
0.9618 High Similarity NPC215875
0.9466 High Similarity NPC279566
0.9389 High Similarity NPC186628
0.9348 High Similarity NPC297600
0.9328 High Similarity NPC103842
0.9323 High Similarity NPC285054
0.927 High Similarity NPC477956
0.9265 High Similarity NPC153979
0.9259 High Similarity NPC156092
0.9259 High Similarity NPC13575
0.922 High Similarity NPC475348
0.922 High Similarity NPC261271
0.9214 High Similarity NPC328623
0.9203 High Similarity NPC265178
0.9203 High Similarity NPC11056
0.9197 High Similarity NPC21350
0.9191 High Similarity NPC41461
0.9191 High Similarity NPC25287
0.9191 High Similarity NPC249606
0.9191 High Similarity NPC150399
0.9191 High Similarity NPC66349
0.9191 High Similarity NPC1486
0.9191 High Similarity NPC477243
0.9191 High Similarity NPC274109
0.9191 High Similarity NPC12165
0.9191 High Similarity NPC477244
0.9191 High Similarity NPC98115
0.9191 High Similarity NPC168105
0.9191 High Similarity NPC213603
0.9191 High Similarity NPC477242
0.9191 High Similarity NPC186838
0.9191 High Similarity NPC24394
0.9161 High Similarity NPC476509
0.9155 High Similarity NPC152233
0.9137 High Similarity NPC40118
0.9137 High Similarity NPC232021
0.9137 High Similarity NPC126534
0.913 High Similarity NPC240305
0.913 High Similarity NPC283429
0.913 High Similarity NPC472366
0.9124 High Similarity NPC472419
0.9124 High Similarity NPC317119
0.9118 High Similarity NPC131039
0.9111 High Similarity NPC144051
0.9111 High Similarity NPC28753
0.9111 High Similarity NPC159623
0.9111 High Similarity NPC82225
0.9111 High Similarity NPC18877
0.9111 High Similarity NPC294593
0.9111 High Similarity NPC204960
0.9111 High Similarity NPC20560
0.9104 High Similarity NPC27490
0.9078 High Similarity NPC282957
0.9078 High Similarity NPC194949
0.9078 High Similarity NPC271288
0.9065 High Similarity NPC259166
0.9065 High Similarity NPC172250
0.9065 High Similarity NPC48624
0.9065 High Similarity NPC215311
0.9065 High Similarity NPC213659
0.9065 High Similarity NPC204985
0.9065 High Similarity NPC144118
0.9065 High Similarity NPC80962
0.9065 High Similarity NPC219917
0.9065 High Similarity NPC477272
0.9065 High Similarity NPC253822
0.9065 High Similarity NPC326109
0.9058 High Similarity NPC251681
0.9058 High Similarity NPC243528
0.9058 High Similarity NPC248995
0.9058 High Similarity NPC477055
0.9058 High Similarity NPC254168
0.9058 High Similarity NPC471620
0.9058 High Similarity NPC477056
0.9058 High Similarity NPC272844
0.9058 High Similarity NPC472368
0.9044 High Similarity NPC286336
0.9034 High Similarity NPC43345
0.903 High Similarity NPC324482
0.9021 High Similarity NPC145467
0.9014 High Similarity NPC25844
0.9014 High Similarity NPC477955
0.9 High Similarity NPC282300
0.9 High Similarity NPC52789
0.9 High Similarity NPC470087
0.9 High Similarity NPC268204
0.9 High Similarity NPC321980
0.9 High Similarity NPC469404
0.9 High Similarity NPC470089
0.9 High Similarity NPC26051
0.9 High Similarity NPC55832
0.8993 High Similarity NPC53181
0.8993 High Similarity NPC295384
0.8993 High Similarity NPC217186
0.8993 High Similarity NPC241975
0.8993 High Similarity NPC470211
0.8993 High Similarity NPC19476
0.8986 High Similarity NPC23870
0.8978 High Similarity NPC101752
0.8973 High Similarity NPC324447
0.8971 High Similarity NPC56031
0.8971 High Similarity NPC242294
0.8971 High Similarity NPC312318
0.8971 High Similarity NPC472365
0.8971 High Similarity NPC27643
0.8971 High Similarity NPC470984
0.8971 High Similarity NPC263670
0.8971 High Similarity NPC337373
0.8971 High Similarity NPC192304
0.8971 High Similarity NPC139813
0.8971 High Similarity NPC175098
0.8971 High Similarity NPC188646
0.8966 High Similarity NPC476551
0.8966 High Similarity NPC476553
0.8966 High Similarity NPC178484
0.8966 High Similarity NPC476552
0.8963 High Similarity NPC475009
0.8963 High Similarity NPC475008
0.8963 High Similarity NPC186097
0.8955 High Similarity NPC84772
0.8951 High Similarity NPC308200
0.8944 High Similarity NPC471473
0.8944 High Similarity NPC473014
0.8944 High Similarity NPC471523
0.8944 High Similarity NPC235217
0.8944 High Similarity NPC476055
0.8944 High Similarity NPC471524
0.8936 High Similarity NPC84266
0.8929 High Similarity NPC241100
0.8929 High Similarity NPC159275
0.8929 High Similarity NPC101366
0.8921 High Similarity NPC470672
0.8921 High Similarity NPC470671
0.8921 High Similarity NPC474487
0.8921 High Similarity NPC183639
0.8921 High Similarity NPC474504
0.8921 High Similarity NPC131130
0.8921 High Similarity NPC219584
0.8921 High Similarity NPC199458
0.8921 High Similarity NPC470083
0.8913 High Similarity NPC174999
0.8913 High Similarity NPC156910
0.8913 High Similarity NPC472367
0.8913 High Similarity NPC473391
0.8913 High Similarity NPC470989
0.8913 High Similarity NPC476333
0.8913 High Similarity NPC470985
0.8913 High Similarity NPC472364
0.8912 High Similarity NPC37253
0.8912 High Similarity NPC79375
0.8897 High Similarity NPC103105
0.8897 High Similarity NPC212631
0.8897 High Similarity NPC470988
0.8897 High Similarity NPC129132
0.8897 High Similarity NPC257756
0.8897 High Similarity NPC205468
0.8897 High Similarity NPC87231
0.8889 High Similarity NPC250057
0.8889 High Similarity NPC39195
0.8881 High Similarity NPC212379
0.8881 High Similarity NPC127059
0.8881 High Similarity NPC470910
0.8881 High Similarity NPC470322
0.8881 High Similarity NPC69235
0.8881 High Similarity NPC285630
0.8881 High Similarity NPC181388
0.8881 High Similarity NPC230818
0.8873 High Similarity NPC470553
0.8873 High Similarity NPC185276
0.8873 High Similarity NPC245482
0.8873 High Similarity NPC117836
0.8873 High Similarity NPC307895
0.8873 High Similarity NPC125894
0.8873 High Similarity NPC51887
0.8873 High Similarity NPC106985
0.8873 High Similarity NPC85162
0.8873 High Similarity NPC11700
0.8873 High Similarity NPC476178
0.8873 High Similarity NPC77794
0.8873 High Similarity NPC278249
0.8873 High Similarity NPC223812
0.8873 High Similarity NPC81697
0.8873 High Similarity NPC301751
0.8873 High Similarity NPC475705
0.8873 High Similarity NPC166138
0.8873 High Similarity NPC107177
0.8873 High Similarity NPC18585
0.8865 High Similarity NPC110969
0.8865 High Similarity NPC110038
0.8865 High Similarity NPC49108
0.8865 High Similarity NPC166689
0.8865 High Similarity NPC285659
0.8865 High Similarity NPC248372
0.8865 High Similarity NPC156190
0.8865 High Similarity NPC279650
0.8865 High Similarity NPC26238

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC322301 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9111 High Similarity NPD6651 Approved
0.8912 High Similarity NPD8443 Clinical (unspecified phase)
0.8824 High Similarity NPD1240 Approved
0.8811 High Similarity NPD4378 Clinical (unspecified phase)
0.8705 High Similarity NPD1510 Phase 2
0.8696 High Similarity NPD1607 Approved
0.8681 High Similarity NPD7410 Clinical (unspecified phase)
0.8592 High Similarity NPD2800 Approved
0.8591 High Similarity NPD7819 Suspended
0.8514 High Similarity NPD4380 Phase 2
0.8451 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8451 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8425 Intermediate Similarity NPD2533 Approved
0.8425 Intermediate Similarity NPD2532 Approved
0.8425 Intermediate Similarity NPD2534 Approved
0.8421 Intermediate Similarity NPD7075 Discontinued
0.8392 Intermediate Similarity NPD1549 Phase 2
0.8392 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8344 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD7411 Suspended
0.828 Intermediate Similarity NPD7473 Discontinued
0.8252 Intermediate Similarity NPD2796 Approved
0.8235 Intermediate Similarity NPD7768 Phase 2
0.8224 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8217 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8141 Intermediate Similarity NPD6959 Discontinued
0.8125 Intermediate Similarity NPD2935 Discontinued
0.8089 Intermediate Similarity NPD6232 Discontinued
0.8063 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8039 Intermediate Similarity NPD1934 Approved
0.8039 Intermediate Similarity NPD6801 Discontinued
0.7987 Intermediate Similarity NPD1511 Approved
0.7987 Intermediate Similarity NPD2801 Approved
0.7987 Intermediate Similarity NPD6799 Approved
0.7949 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7931 Intermediate Similarity NPD2799 Discontinued
0.7931 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7908 Intermediate Similarity NPD6599 Discontinued
0.7905 Intermediate Similarity NPD3750 Approved
0.7887 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7885 Intermediate Similarity NPD3882 Suspended
0.7881 Intermediate Similarity NPD1512 Approved
0.7867 Intermediate Similarity NPD7390 Discontinued
0.7838 Intermediate Similarity NPD1243 Approved
0.7838 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7785 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7764 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7764 Intermediate Similarity NPD6166 Phase 2
0.7764 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7758 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7755 Intermediate Similarity NPD6099 Approved
0.7755 Intermediate Similarity NPD1551 Phase 2
0.7755 Intermediate Similarity NPD6100 Approved
0.775 Intermediate Similarity NPD5710 Approved
0.775 Intermediate Similarity NPD5711 Approved
0.7744 Intermediate Similarity NPD5953 Discontinued
0.7736 Intermediate Similarity NPD5494 Approved
0.773 Intermediate Similarity NPD2798 Approved
0.7722 Intermediate Similarity NPD3749 Approved
0.7707 Intermediate Similarity NPD3817 Phase 2
0.7703 Intermediate Similarity NPD2344 Approved
0.7683 Intermediate Similarity NPD7074 Phase 3
0.7655 Intermediate Similarity NPD943 Approved
0.7639 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7622 Intermediate Similarity NPD7054 Approved
0.7622 Intermediate Similarity NPD7286 Phase 2
0.76 Intermediate Similarity NPD2654 Approved
0.7597 Intermediate Similarity NPD920 Approved
0.7576 Intermediate Similarity NPD7472 Approved
0.7568 Intermediate Similarity NPD3748 Approved
0.7566 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7561 Intermediate Similarity NPD3818 Discontinued
0.755 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7547 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7545 Intermediate Similarity NPD7808 Phase 3
0.7517 Intermediate Similarity NPD2313 Discontinued
0.75 Intermediate Similarity NPD2309 Approved
0.75 Intermediate Similarity NPD3226 Approved
0.75 Intermediate Similarity NPD6832 Phase 2
0.75 Intermediate Similarity NPD7458 Discontinued
0.75 Intermediate Similarity NPD4908 Phase 1
0.7485 Intermediate Similarity NPD6559 Discontinued
0.7485 Intermediate Similarity NPD7251 Discontinued
0.7484 Intermediate Similarity NPD5403 Approved
0.7468 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7447 Intermediate Similarity NPD3972 Approved
0.7434 Intermediate Similarity NPD4628 Phase 3
0.7425 Intermediate Similarity NPD6797 Phase 2
0.7413 Intermediate Similarity NPD1203 Approved
0.7397 Intermediate Similarity NPD3268 Approved
0.7378 Intermediate Similarity NPD3926 Phase 2
0.7376 Intermediate Similarity NPD1610 Phase 2
0.7372 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7365 Intermediate Similarity NPD5124 Phase 1
0.7365 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD5401 Approved
0.7351 Intermediate Similarity NPD2346 Discontinued
0.732 Intermediate Similarity NPD7003 Approved
0.7314 Intermediate Similarity NPD4363 Phase 3
0.7314 Intermediate Similarity NPD4360 Phase 2
0.7305 Intermediate Similarity NPD5844 Phase 1
0.7299 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7292 Intermediate Similarity NPD2797 Approved
0.7292 Intermediate Similarity NPD1164 Approved
0.7286 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7285 Intermediate Similarity NPD5408 Approved
0.7285 Intermediate Similarity NPD5404 Approved
0.7285 Intermediate Similarity NPD5405 Approved
0.7285 Intermediate Similarity NPD5406 Approved
0.7273 Intermediate Similarity NPD4361 Phase 2
0.7273 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD5402 Approved
0.7254 Intermediate Similarity NPD1201 Approved
0.7239 Intermediate Similarity NPD919 Approved
0.7235 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7232 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD1876 Approved
0.7219 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7205 Intermediate Similarity NPD1465 Phase 2
0.7203 Intermediate Similarity NPD9717 Approved
0.7203 Intermediate Similarity NPD1608 Approved
0.7194 Intermediate Similarity NPD9493 Approved
0.7188 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7172 Intermediate Similarity NPD1470 Approved
0.7152 Intermediate Similarity NPD1247 Approved
0.7143 Intermediate Similarity NPD37 Approved
0.7134 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7133 Intermediate Similarity NPD422 Phase 1
0.7133 Intermediate Similarity NPD230 Phase 1
0.7133 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7124 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7123 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7111 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7108 Intermediate Similarity NPD7229 Phase 3
0.7105 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD7033 Discontinued
0.7103 Intermediate Similarity NPD1283 Approved
0.7095 Intermediate Similarity NPD4625 Phase 3
0.7093 Intermediate Similarity NPD8312 Approved
0.7093 Intermediate Similarity NPD8313 Approved
0.7092 Intermediate Similarity NPD9545 Approved
0.7092 Intermediate Similarity NPD1548 Phase 1
0.7086 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD1729 Discontinued
0.7055 Intermediate Similarity NPD3267 Approved
0.7055 Intermediate Similarity NPD3266 Approved
0.7047 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD3764 Approved
0.7042 Intermediate Similarity NPD1651 Approved
0.7041 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7034 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7034 Intermediate Similarity NPD4749 Approved
0.703 Intermediate Similarity NPD6234 Discontinued
0.7025 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7024 Intermediate Similarity NPD2403 Approved
0.702 Intermediate Similarity NPD6355 Discontinued
0.7012 Intermediate Similarity NPD4965 Approved
0.7012 Intermediate Similarity NPD4967 Phase 2
0.7012 Intermediate Similarity NPD4966 Approved
0.6993 Remote Similarity NPD17 Approved
0.6993 Remote Similarity NPD4308 Phase 3
0.6989 Remote Similarity NPD8151 Discontinued
0.698 Remote Similarity NPD3027 Phase 3
0.6971 Remote Similarity NPD8434 Phase 2
0.6971 Remote Similarity NPD8150 Discontinued
0.6962 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6957 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6951 Remote Similarity NPD4288 Approved
0.6951 Remote Similarity NPD2296 Approved
0.6946 Remote Similarity NPD7199 Phase 2
0.6914 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6908 Remote Similarity NPD1899 Clinical (unspecified phase)
0.6903 Remote Similarity NPD1471 Phase 3
0.6903 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6903 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6903 Remote Similarity NPD6004 Phase 3
0.6903 Remote Similarity NPD6005 Phase 3
0.6903 Remote Similarity NPD6002 Phase 3
0.6902 Remote Similarity NPD7698 Approved
0.6902 Remote Similarity NPD7697 Approved
0.6902 Remote Similarity NPD7696 Phase 3
0.6897 Remote Similarity NPD1281 Approved
0.6893 Remote Similarity NPD4287 Approved
0.689 Remote Similarity NPD8455 Phase 2
0.6882 Remote Similarity NPD7584 Approved
0.6879 Remote Similarity NPD6104 Discontinued
0.6875 Remote Similarity NPD4626 Approved
0.6871 Remote Similarity NPD3225 Approved
0.6865 Remote Similarity NPD7871 Phase 2
0.6865 Remote Similarity NPD7870 Phase 2
0.6864 Remote Similarity NPD7184 Clinical (unspecified phase)
0.6846 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6842 Remote Similarity NPD4060 Phase 1
0.6842 Remote Similarity NPD7228 Approved
0.6839 Remote Similarity NPD4477 Approved
0.6839 Remote Similarity NPD4476 Approved
0.6831 Remote Similarity NPD6781 Approved
0.6831 Remote Similarity NPD6778 Approved
0.6831 Remote Similarity NPD6782 Approved
0.6831 Remote Similarity NPD6776 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data